Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C G Steward

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Bailliere'S Best Practice & Research. Clinical Haematology|October 13, 2000
Stem cell transplantation for non-malignant disordersC G Steward
Neuropathology and Applied Neurobiology|March 29, 2003
Neurological aspects of osteopetrosisC G Steward
Archives of Disease in Childhood|November 23, 2005
Haemopoietic stem cell transplantation for genetic disordersC G Steward, A Jarisch
Bone Marrow Transplantation|March 7, 2003
Hematopoietic cell transplantation for inherited metabolic diseases: an overview of outcomes and practice guidelinesC Peters, C G Steward, , et al.
Bone Marrow Transplantation|April 7, 2005
Hematopoietic cell transplantation activity in Europe for inherited metabolic diseases: open issues and future directionsA M Rovelli, C G Steward
British Journal of Haematology|March 1, 1993
The significance of detection of minimal residual disease in childhood acute lymphoblastic leukaemiaM N Potter, C G Steward, A Oakhill
Leukemia|November 1, 1992
Third complementarity determining region (CDR III) sequence analysis in childhood B-lineage acute lymphoblastic leukaemia: implications for the design of oligonucleotide probes for use in monitoring minimal residual diseaseC G Steward, M N Potter, A Oakhill
Journal of Inherited Metabolic Disease|September 10, 2005
Bone marrow transplantation correcting beta-galactosidase activity does not influence neurological outcome in juvenile GM1-gangliosidosisJ P H Shield, J Stone, C G Steward
Pediatric Radiology|December 1, 2001
Imaging of malignant infantile osteopetrosis before and after bone marrow transplantationH K Cheow, C G Steward, D J Grier
Scandinavian Journal of Immunology|September 26, 2003
Optimization of functional efficacy of phosphorothioate-modified oligonucleotides in a human CD8+ T-cell ex vivo expansion modelN A Al-Shanti, C G Steward, R J Garland
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Bailliere'S Best Practice & Research. Clinical Haematology|October 13, 2000
Stem cell transplantation for non-malignant disordersC G Steward
Neuropathology and Applied Neurobiology|March 29, 2003
Neurological aspects of osteopetrosisC G Steward
Archives of Disease in Childhood|November 23, 2005
Haemopoietic stem cell transplantation for genetic disordersC G Steward, A Jarisch
Bone Marrow Transplantation|March 7, 2003
Hematopoietic cell transplantation for inherited metabolic diseases: an overview of outcomes and practice guidelinesC Peters, C G Steward, , et al.
Bone Marrow Transplantation|April 7, 2005
Hematopoietic cell transplantation activity in Europe for inherited metabolic diseases: open issues and future directionsA M Rovelli, C G Steward
British Journal of Haematology|March 1, 1993
The significance of detection of minimal residual disease in childhood acute lymphoblastic leukaemiaM N Potter, C G Steward, A Oakhill
Leukemia|November 1, 1992
Third complementarity determining region (CDR III) sequence analysis in childhood B-lineage acute lymphoblastic leukaemia: implications for the design of oligonucleotide probes for use in monitoring minimal residual diseaseC G Steward, M N Potter, A Oakhill
Journal of Inherited Metabolic Disease|September 10, 2005
Bone marrow transplantation correcting beta-galactosidase activity does not influence neurological outcome in juvenile GM1-gangliosidosisJ P H Shield, J Stone, C G Steward
Pediatric Radiology|December 1, 2001
Imaging of malignant infantile osteopetrosis before and after bone marrow transplantationH K Cheow, C G Steward, D J Grier
Scandinavian Journal of Immunology|September 26, 2003
Optimization of functional efficacy of phosphorothioate-modified oligonucleotides in a human CD8+ T-cell ex vivo expansion modelN A Al-Shanti, C G Steward, R J Garland
Pageof 6